| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| ABBOTT LABORATORIES | EXECUTIVE VICE PRESIDENT | Common shares without par value | 118,380 | $12,785,040 | $108.00 | 01 Mar 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 28 Feb 2023 | 2 | -$779,283 | 4 | EXECUTIVE VICE PRESIDENT | 02 Mar 2023, 18:36 |
| ABT | ABBOTT LABORATORIES | 17 Feb 2023 | 2 | $0 | 4 | EXECUTIVE VICE PRESIDENT | 22 Feb 2023, 17:56 |
| ABT | ABBOTT LABORATORIES | 13 Dec 2022 | 1 | -$1,235,520 | 4 | EXECUTIVE VICE PRESIDENT | 15 Dec 2022, 16:26 |
| ABT | ABBOTT LABORATORIES | 03 Jun 2022 | 1 | -$207,758 | 4 | EXECUTIVE VICE PRESIDENT | 07 Jun 2022, 17:14 |
| ABT | ABBOTT LABORATORIES | 28 Feb 2022 | 2 | -$762,410 | 4 | EXECUTIVE VICE PRESIDENT | 02 Mar 2022, 18:47 |
| ABT | ABBOTT LABORATORIES | 18 Feb 2022 | 2 | $0 | 4 | EXECUTIVE VICE PRESIDENT | 23 Feb 2022, 19:15 |
| ABT | ABBOTT LABORATORIES | 27 Oct 2021 | 3 | -$1,642,787 | 4 | EXECUTIVE VICE PRESIDENT | 27 Oct 2021, 18:45 |
| ABT | ABBOTT LABORATORIES | 03 Jun 2021 | 1 | -$188,999 | 4 | EXECUTIVE VICE PRESIDENT | 07 Jun 2021, 17:31 |